Pharma BD Deal Intelligence
GlaxoSmithKline plc / Laboratorios Phoenix
2010 · Acquisition/Merger · $253M · Complete
Announcement Sentiment
71
Positive
GSK acquired Argentine generics maker Laboratorios Phoenix for $253M to drive Latin America growth strategy.
Key facts
- Announced Aug 25, 2010
- Deal value $253M
- Deal type Acquisition/Merger
- Therapeutic area Cardiology, GI, neuroscience, metabolic, urology, analgesics
- Indications Cardiology, GI, neuroscience, metabolic, urology, analgesics
- Key assets Argentine branded generics portfolio
- Mechanism Branded generics
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals